Results 1 to 10 of about 16,017 (247)

Regional Intestinal Drug Absorption: Biopharmaceutics and Drug Formulation

open access: yesPharmaceutics, 2021
The gastrointestinal tract (GIT) can be broadly divided into several regions: the stomach, the small intestine (which is subdivided to duodenum, jejunum, and ileum), and the colon. The conditions and environment in each of these segments, and even within
Arik Dahan, Isabel González-Álvarez
core   +2 more sources

Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. [PDF]

open access: yesPharmaceutics
Background/Objectives: Nasal biopharmaceutics is the scientific understanding of product and patient factors that determine the rate and extent of drug exposure following nasal administration. The authors considered whether current biopharmaceutics tools
Forbes B   +7 more
europepmc   +4 more sources

Physiologically Based Biopharmaceutics Model of Apixaban for Biopharmaceutics Risk Assessment

open access: yesPharmaceutics
Background/Objectives: This study applies a Physiologically Based Biopharmaceutics Modeling (PBBM) framework to predict the bioavailability (BA) and bioequivalence (BE) of apixaban, a borderline BCS Class III/IV drug.
José A. G. Morais   +5 more
core   +2 more sources

Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling

open access: yesPharmaceutics, 2022
The development of extended-release dosage forms with adequate drug release is a challenge for pharmaceutical companies, mainly when the drug presents high solubility, as in Biopharmaceutics Classification System (BCS) class I.
de Souza, Natalia Vieira   +9 more
core   +2 more sources

Gliclazide: Biopharmaceutics Characteristics to Discuss the Biowaiver of Immediate and Extended Release Tablets

open access: yesApplied Sciences, 2020
The lists of essential medicines of the World Health Organization (WHO) and Brazil include gliclazide as an alternative to the oral antidiabetic drug of first choice, metformin, in the treatment of type 2 diabetes mellitus because of its pharmacokinetic ...
Jacqueline Souza   +9 more
core   +2 more sources

Integrated biopharmaceutical approach in pharmaceutical development and drug characterization: General concept and application [PDF]

open access: yesHemijska Industrija, 2020
The importance of biopharmaceutical considerations in pharmaceutical development and drug characterization has been well recognized both by pharmaceutical industry and regulatory authorities as a tool to establish predictive relationships ...
Cvijić Sandra V.   +2 more
doaj   +1 more source

The Evolving Role of In Vitro-In Vivo Correlation in Model-Informed Drug Development: A Multi-Stakeholder Perspective. [PDF]

open access: yesCPT Pharmacometrics Syst Pharmacol
In vitro–in vivo correlation/relationship (IVIVC/R) models such as physiologically based biopharmaceutics modeling (PBBM) are crucial tools that link biopharmaceutical properties to clinical performance.
Chenel M   +7 more
europepmc   +2 more sources

Biopharmaceutics [PDF]

open access: yes, 2023
Biopharmaceutics, in connection with pharmacokinetics, is the field that investigates and describes everything that happens with a medicinal product and the active substance between the moment of administration, the moment it exerts its action and the ...
Lagarce, Frederic   +3 more
core   +1 more source

Production of Recombinant E.coli Asparaginase on a Laboratory Scale [PDF]

open access: yesمجله دانشکده پزشکی اصفهان, 2023
Background: L-asparaginase is an enzyme derived from E. coli and is one of the drugs used to treat acute lymphoblastic leukemia. Decreased blood asparagine after the use of the asparaginase can lead to death for these cells. The aim of this project is to
Zahra Zeinali, Hamid Bakherad
doaj   +1 more source

Integrating In Vitro Biopharmaceutics into Physiologically Based Biopharmaceutic Model (PBBM) to Predict Food Effect of BCS IV Zwitterionic Drug (GSK3640254)

open access: yesPharmaceutics, 2023
A strategy followed to integrate in vitro solubility and permeability data into a PBBM model to predict the food effect of a BCS IV zwitterionic drug (GSK3640254) observed in clinical studies is described.
Konstantinos Stamatopoulos   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy